Taltz and Peripheral swelling - a phase IV clinical study of FDA data

Summary:

Peripheral swelling is found among people who take Taltz, especially for people who are female, 50-59 old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Taltz and have Peripheral swelling. It is created by eHealthMe based on reports of 16,468 people who have side effects when taking Taltz from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On May, 16, 2022

16,468 people reported to have side effects when taking Taltz.
Among them, 143 people (0.87%) have Peripheral swelling.


What is Taltz?

Taltz has active ingredients of ixekizumab. eHealthMe is studying from 16,482 Taltz users for its effectiveness, alternative drugs and more.

What is Peripheral swelling?

Peripheral swelling is found to be associated with 1,896 drugs and 1,523 conditions by eHealthMe.

Number of Taltz and Peripheral swelling reports submitted per year:

Could Taltz cause Peripheral swelling?

Time on Taltz when people have Peripheral swelling *:

Click here to view

Gender of people who have Peripheral swelling when taking Taltz*:

Click here to view

Age of people who have Peripheral swelling when taking Taltz *:

Click here to view

Common drugs people take besides Taltz *:

Click here to view

Common side effects people have besides Peripheral swelling *:

Click here to view

Common conditions people have *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Taltz and have Peripheral swelling?

Check whether Peripheral swelling is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of Taltz:

Peripheral swelling treatments and more:

COVID vaccines that are related to Peripheral swelling:

How severe was Peripheral swelling and when was it recovered:

Expand to all the drugs that have ingredients of ixekizumab:

Common drugs associated with Peripheral swelling:

All the drugs that are associated with Peripheral swelling:

Common conditions associated with Peripheral swelling:

All the conditions that are associated with Peripheral swelling:

How the study uses the data?

The study uses data from the FDA. It is based on ixekizumab (the active ingredients of Taltz) and Taltz (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: